ISSCR News
![The ISSCR Announces 2021 Award Recipients](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/1658419712483-V3MUQC048935TFNT6VS3/unsplash-image-HkN64BISuQA.jpg)
The ISSCR Announces 2021 Award Recipients
Stem cell scientists and leaders earn 2021 ISSCR Awards for their significant scientific contributions to stem cell research and regenerative medicine. Honorees will be recognized at ISSCR 2021 Virtual, the society's hallmark annual meeting 21-26 June, 2021.
![ISSCR Board Authors Commentary in Stem Cell Reports Responding to Flawed Study on Female Mentors and Mentees in Science](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/1660336718556-1SMYK2CYXWSH9LZGLZUY/Untitled+design+%2815%29.png)
ISSCR Board Authors Commentary in Stem Cell Reports Responding to Flawed Study on Female Mentors and Mentees in Science
The ISSCR Board of Directors collaborated on a commentary published in Stem Cell Reports today titled, Mentorship in Science: Response to AlShebli et al., Nature Communications 2020. While the controversial paper, originally published in November 2020, was retracted on 21 December 2020, the message remains an important statement from the society and reinforces ISSCR's commitment to creating meaningful opportunities for women at all levels in their careers to thrive and succeed in stem cell science.
![Member Spotlight: Lijian Hui, PhD](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/4d19560b-a45a-484c-8c3a-7e9759219065/Lijian_Hui_500x500.png)
Member Spotlight: Lijian Hui, PhD
“I think the ISSCR provides me the largest platform to show our findings and it’s an international community where people share each other’s progress”.
![The ISSCR Comments on EMA Draft Guidance on Registry-based Studies](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/1658421443219-4Z9WYSUGM72VOCC60TSZ/unsplash-image-uCMKx2H1Y38.jpg)
The ISSCR Comments on EMA Draft Guidance on Registry-based Studies
The ISSCR recently delivered comments on the draft Guideline on Registry-based Studies (EMA/502388/2020). Among other points, the letter stated support the crucial role of the European Medicines Agency (EMA) in overseeing the development of safe and effective new products and the draft Guideline on Registry-based Studies. The Society also encouraged EMA to clarify the appropriate uses for patient registries to prevent them from being abused by businesses seeking to prematurely commercialize unproven stem cell-based interventions.
![](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/1e898b25-2b77-4f85-aea4-e33ef01a920e/mouse+neural+stem+cell.jpg)
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .